ChemSpider 2D Image | pyridostigmine bromide | C9H13BrN2O2

pyridostigmine bromide

  • Molecular FormulaC9H13BrN2O2
  • Average mass261.116 Da
  • Monoisotopic mass260.016022 Da
  • ChemSpider ID7269

  • Charge - Charge

More details:

Featured data source
The Merck Index Online

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

101-26-8 [RN]
202-929-9 [EINECS]
3-(Dimethylaminocarbonyloxy)-1-methylpyridinium bromide
3-[(dimethylcarbamoyl)oxy]-1-methylpyridin-1-ium bromide
3-[(Dimethylcarbamoyl)oxy]-1-methylpyridinium bromide [ACD/IUPAC Name]
3-[(Dimethylcarbamoyl)oxy]-1-methylpyridiniumbromid [German] [ACD/IUPAC Name]
3-[[(Dimethylamino)carbonyl]oxy]-1-methylpyridinium Bromide
3-{[(dimethylamino)carbonyl]oxy}-1-methylpyridinium bromide
Bromure de 3-[(diméthylcarbamoyl)oxy]-1-méthylpyridinium [French] [ACD/IUPAC Name]
Bromure de pyridostigmine [French] [INN]
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

278 [DBID]
CCRIS 6798 [DBID]
D00487 [DBID]
EU-0101035 [DBID]
HSDB 3924 [DBID]
MLS000028385 [DBID]
NSC679759 [DBID]
P9797_SIGMA [DBID]
SMR000058605 [DBID]
  • Experimental Physico-chemical Properties
  • Predicted Physico-chemical Properties
  • Miscellaneous

    • Target Organs:

      AChE inhibitor TargetMol T0780

    • Bio Activity:

      AChE MedChem Express HY-B0207A
      AChE TargetMol T0780
      Neuronal Signaling MedChem Express HY-B0207A
      Neuronal Signaling; MedChem Express HY-B0207A
      Neuroscience TargetMol T0780
      Pyridostigmine is a parasympathomimetic and a reversible cholinesterase inhibitor. MedChem Express
      Pyridostigmine is a parasympathomimetic and a reversible cholinesterase inhibitor.; Target: AChE; Pyridostigmine is a parasympathomimetic and a reversible cholinesterase inhibitor. MedChem Express HY-B0207A
      Pyridostigmine is a parasympathomimetic and a reversible cholinesterase inhibitor.;Target: AChEPyridostigmine is a parasympathomimetic and a reversible cholinesterase inhibitor. Since it is a quaternary amine, it is poorly absorbed in the gut and does not cross the blood?brain barrier, except possibly in stressful conditions. Pyridostigmine inhibits acetylcholinesterase in the synaptic cleft, thus slowing down the hydrolysis of acetylcholine. It is a quaternary carbamate inhibitor of cholinesterase that does not cross the blood?brain barrier which carbamylates about 30% of peripheral cholinesterase enzyme. The carbamylated enzyme eventually regenerates by natural hydrolysis and excess ACh levels revert to normal.Pyridostigmine is used to treat muscle weakness in people with myasthenia gravis and to combat the effects of curariform drug toxicity. Pyridostigmine bromide has been FDA approved for military use during combat situations as an agent to be given prior to exposure to the MedChem Express HY-B0207A

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site


Advertisement